Quick Answer
VSEE HEALTH, INC. reported Diluted EPS of $0.73 per share (loss) for fiscal year 2025.
VSEE HEALTH, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.73 | +87.1% |
| 2024 | -$5.65 | -1386.8% |
| 2023 | -$0.38 | -52.0% |
| 2022 | -$0.25 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | +99.4% | +87.5% |
| June 30, 2025 | -$0.16 | -33.3% | +33.3% |
| March 31, 2025 | -$0.24 | -2500.0% | +93.3% |
| September 30, 2024 | -$3.58 | -35700.0% | -2883.3% |
| June 30, 2024 | -$0.12 | -33.3% | -1300.0% |
| March 31, 2024 | $0.01 | +102.2% | +200.0% |
| September 30, 2023 | -$0.01 | +80.0% | +88.9% |
| June 30, 2023 | -$0.09 | -125.0% | +80.0% |
- VSEE HEALTH, INC. showed an increase of +87.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, VSEE HEALTH, INC.’s diluted eps has declined by 192.0% (from $0.25 per share (loss) to $0.73 per share (loss)).
- The most recent figure is from VSEE HEALTH, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: